Literature DB >> 34170795

Early Lung Disease Exhibits Bacteria-Dependent and -Independent Abnormalities in Cystic Fibrosis Pigs.

Drake C Bouzek1, Mahmoud H Abou Alaiwa1,2, Ryan J Adam1,3, Alejandro A Pezzulo1,2, Leah R Reznikov1, Daniel P Cook1, Maria I Aguilar Pescozo1, Patrick Ten Eyck4, Chaorong Wu4, Thomas J Gross1, Douglas B Hornick1, Eric A Hoffman3,5, David K Meyerholz6, David A Stoltz1,2,3,7.   

Abstract

Rationale: Although it is clear that cystic fibrosis (CF) airway disease begins at a very young age, the early and subsequent steps in disease pathogenesis and the relative contribution of infection, mucus, and inflammation are not well understood.
Objectives: As one approach to assessing the early contribution of infection, we tested the hypothesis that early and continuous antibiotics would decrease the airway bacterial burden. We believed that, if they do, this might reveal aspects of the disease that are more or less sensitive to decreasing infection.
Methods: Three groups of pigs were studied from birth until ∼3 weeks of age: 1) wild-type, 2) CF, and 3) CF pigs treated continuously with broad-spectrum antibiotics from birth until study completion. Disease was assessed with chest computed tomography, histopathology, microbiology, and BAL. Measurements and Main
Results: Disease was present by 3 weeks of age in CF pigs. Continuous antibiotics from birth improved chest computed tomography imaging abnormalities and airway mucus accumulation but not airway inflammation in the CF pig model. However, reducing bacterial infection did not improve two disease features already present at birth in CF pigs: air trapping and submucosal gland duct plugging. In the CF sinuses, antibiotics did not prevent the development of infection or disease or the number of bacteria but did alter the bacterial species. Conclusions: These findings suggest that CF airway disease begins immediately after birth and that early and continuous antibiotics impact some, but not all, aspects of CF lung disease development.

Entities:  

Keywords:  antibacterial agents; lung physiology; mucus; multidetector computed tomography; respiratory mucosa

Mesh:

Substances:

Year:  2021        PMID: 34170795      PMCID: PMC8521711          DOI: 10.1164/rccm.202102-0451OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   30.528


  52 in total

1.  The mucus bundles responsible for airway cleaning are retained in cystic fibrosis and by cholinergic stimulation.

Authors:  Anna Ermund; Lauren N Meiss; Brendan Dolan; Andrea Bähr; Nikolai Klymiuk; Gunnar C Hansson
Journal:  Eur Respir J       Date:  2018-08-30       Impact factor: 16.671

2.  Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets.

Authors:  Xingshen Sun; Alicia K Olivier; Yaling Yi; Christopher E Pope; Hillary S Hayden; Bo Liang; Hongshu Sui; Weihong Zhou; Kyle R Hager; Yulong Zhang; Xiaoming Liu; Ziying Yan; John T Fisher; Nicholas W Keiser; Yi Song; Scott R Tyler; J Adam Goeken; Joann M Kinyon; Matthew C Radey; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Mitchell J Brittnacher; Samuel I Miller; Kalpaj Parekh; David K Meyerholz; Lucas R Hoffman; Timothy Frana; Zoe A Stewart; John F Engelhardt
Journal:  Am J Pathol       Date:  2014-03-15       Impact factor: 4.307

3.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

4.  Differences in the lower airway microbiota of infants with and without cystic fibrosis.

Authors:  Katherine B Frayman; Kristine M Wylie; David S Armstrong; Rosemary Carzino; Stephanie D Davis; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Sarath C Ranganathan
Journal:  J Cyst Fibros       Date:  2018-12-21       Impact factor: 5.482

5.  Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis.

Authors:  Kathryn A Ramsey; Tim Rosenow; Lidija Turkovic; Billy Skoric; Georgia Banton; Anne-Marie Adams; Shannon J Simpson; Conor Murray; Sarath C Ranganathan; Stephen M Stick; Graham L Hall
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

Review 6.  Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis.

Authors:  Paul M Quinton
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

7.  High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.

Authors:  Alan S Brody; Jeffrey S Klein; Paul L Molina; Joanne Quan; Judy A Bean; Robert W Wilmott
Journal:  J Pediatr       Date:  2004-07       Impact factor: 4.406

Review 8.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

9.  Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets.

Authors:  Bradley H Rosen; T Idil Apak Evans; Shashanna R Moll; Jaimie S Gray; Bo Liang; Xingshen Sun; Yulong Zhang; Chandler W Jensen-Cody; Anthony M Swatek; Weihong Zhou; Nan He; Pavana G Rotti; Scott R Tyler; Nicholas W Keiser; Preston J Anderson; Leonard Brooks; Yalan Li; R Marshall Pope; Maheen Rajput; Eric A Hoffman; Kai Wang; J Kirk Harris; Kalpaj R Parekh; Katherine N Gibson-Corley; John F Engelhardt
Journal:  Am J Respir Crit Care Med       Date:  2018-05-15       Impact factor: 30.528

10.  Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year.

Authors:  Gwyneth Davies; Lena P Thia; Janet Stocks; Andrew Bush; Ah-Fong Hoo; Angie Wade; The Thanh Diem Nguyen; Alan S Brody; Alistair Calder; Nigel J Klein; Siobhán B Carr; Colin Wallis; Ranjan Suri; Caroline S Pao; Gary Ruiz; Ian M Balfour-Lynn
Journal:  J Cyst Fibros       Date:  2020-02-07       Impact factor: 5.482

View more
  2 in total

Review 1.  Animal models of cystic fibrosis in the era of highly effective modulator therapies.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico
Journal:  Curr Opin Pharmacol       Date:  2022-05-13       Impact factor: 4.768

2.  Tromethamine improves mucociliary clearance in cystic fibrosis pigs.

Authors:  Jamison J Ash; Brieanna M Hilkin; Nicholas D Gansemer; Eric A Hoffman; Joseph Zabner; David A Stoltz; Mahmoud H Abou Alaiwa
Journal:  Physiol Rep       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.